Global Healthcare Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.

Press releases published on May 30, 2026

 HSA for America Urges Americans to Start Open Enrollment Planning Now, Not in November
Momcozy สร้างความเชื่อมั่นก่อนตัดสินใจซื้อในกลุ่มคุณแม่เอเชียตะวันออกเฉียงใต้ ต้อนรับแคมเปญ 6.6
Momcozy Perkuat Kepercayaan Ibu Asia Tenggara Sebelum Berbelanja di Momen 6.6
Momcozy កំពុងកសាងទំនុកចិត្តមុនពេលទិញក្នុងចំណោមម្ដាយអាស៊ីអាគ្នេយ៍ មុនយុទ្ធនាការ 6.6
Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6
Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6
Beyond the Cart: How Momcozy is Securing 'Pre-Checkout Trust' Among Southeast Asian Mothers Ahead of 6.6
Author Ani Retak Unveils 'Breathe Wisely': A Self-Help Guide on Breath and Nervous System Awareness
Synergy Rehab Continues Expanding Multidisciplinary Rehabilitation Across British Columbia With Patient-First Care
The Growing Conversation Around Oxygen Therapy and Cellular Recovery
Orion Pharma announces first results from Phase 1/2 TEADES trial with TEAD inhibitor ODM-212 in patients with advanced solid tumours
Orion Pharma julkisti ensimmäiset tulokset Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) potilailla, joilla on kiinteitä kasvaimia ja edennyt syöpä
Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology
Globale Daten der ROSETTA Lung-02-Studie: Ermutigende Wirksamkeit für BioNTechs und Bristol Myers Squibbs bispezifischen PD-L1xVEGF-A-Immunmodulator-Kandidat Pumitamig bei nicht-kleinzelligem Lungenkrebs
Global Data for BioNTech and Bristol Myers Squibb’s PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial
ITM Announces Phase 3 COMPETE Patient-Reported Quality of Life Data with n.c.a. ¹⁷⁷Lu-edotreotide (ITM-11) vs. Everolimus at ASCO 2026
Mineralys Therapeutics Presents New Data from the Phase 3 Launch-HTN Trial of Lorundrostat in Participants with Hypertension and Chronic Kidney Disease at European Meeting on Hypertension and Cardiovascular Protection (ESH 2026)
Ourian Plastic Surgery Announces Updated Content on Breast Reduction with PPO Insurance
Vapofil Reviews [URGENT REPORT 2026] The Shocking VapoFil Male Enhancement Supplement Trend Everyone Is Talking About
ImPact Biotech Presents Updated Data from Phase 1 Trial of Padeliporfin VTP in LA-PDAC and Phase 3 ENLIGHTED Trial in LG-UTUC at ASCO 2026

Share this page:

Sign up for:

Global Healthcare Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.